BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.06% | 17.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.37% | 17.72% | |||
| Cost of Revenue | 19.38% | -0.24% | |||
| Gross Profit | 5.66% | 20.84% | |||
| SG&A Expenses | -1.66% | 17.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.77% | 10.96% | |||
| Operating Income | 85.60% | 691.61% | |||
| Income Before Tax | 47.83% | 376.31% | |||
| Income Tax Expenses | 326.91% | -73.36% | |||
| Earnings from Continuing Operations | 32.36% | 7,326.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.36% | 7,326.77% | |||
| EBIT | 85.60% | 691.61% | |||
| EBITDA | 68.88% | 175.55% | |||
| EPS Basic | 30.09% | 7,216.81% | |||
| Normalized Basic EPS | 53.93% | 341.43% | |||
| EPS Diluted | 33.33% | 6,742.11% | |||
| Normalized Diluted EPS | 53.94% | 341.60% | |||
| Average Basic Shares Outstanding | 1.75% | 1.30% | |||
| Average Diluted Shares Outstanding | 1.74% | 1.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||